Toggle navigation
Toggle navigation
Home
DCUM Forums
Nanny Forums
Events
About DCUM
Advertising
Search
Recent Topics
Hottest Topics
FAQs and Guidelines
Privacy Policy
Your current identity is: Anonymous
Login
Preview
Subject:
Forum Index
»
Health and Medicine
Reply to "Only ~14% Of U.S. Adults Have Gotten Latest Covid-19 Vaccine Update"
Subject:
Emoticons
More smilies
Text Color:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Violet
White
Black
Font:
Very Small
Small
Normal
Big
Giant
Close Marks
[quote=Anonymous]The CDC's overstatement of covid booster uptake is becoming more obvious each day. The CDC's NIS-ACM phone survey is currently reporting that 23% of US adults have taken the new booster. That is higher than the 21% share of adults who took last fall's bivalent booster; that defies logic. States are reporting less uptake of the current booster relative to last year's booster while Pfizer, Moderna, and BioNTech have all reported sharply lower revenues for covid vaccines in Q4-2023 compared to Q4-2022. Why is the CDC citing NIS-ACM data when its results are not tethered to reality? https://www.cnbc.com/2024/01/30/pfizer-pfe-q4-earnings-report-2023.html "Pfizer’s Covid vaccine raked in $5.36 billion in revenue for the quarter [Q4-2023], down 53% from the same period last year [Q4-2022]. ... Pfizer CEO Albert Bourla told CNBC around [b]15%[/b] of the U.S. population received an updated Covid vaccine this fall and winter." [[i]Note: Bourla's figure comports with what state data is showing.[/i]] https://www.cnbc.com/2024/02/22/moderna-mrna-earnings-q4-2023.html "The biotech company [Moderna] booked fourth-quarter sales of $2.81 billion, with revenue from its Covid shot dropping 43% from the same period a year ago. That decline was primarily driven by lower vaccine volume" https://www.msn.com/en-us/money/markets/biontech-tumbles-as-q4-profit-sales-trail-estimates-on-falling-covid-19-vaccine-demand/ar-BB1keAWj"BioNTech reported fourth-quarter profit and sales that were well below estimates on falling demand for COVID-19 vaccines. ... revenue slumping 65% to 1.48 billion euros ($1.60 billion) [in Q4-2023] over the same period a year ago [Q4-2022]" [/quote]
Options
Disable HTML in this message
Disable BB Code in this message
Disable smilies in this message
Review message
Search
Recent Topics
Hottest Topics